You are here

Revive Therapeutics' experimental COVID treatment fails in late-stage study

Primary tabs

...

The company was evaluating the safety and efficacy of its oral treatment, bucillamine, in the study which enrolled 713 patients with mild to moderate COVID-19.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
howdy folks
Page loaded in 0.475 seconds.